CD276 and central nervous system cancer: Similar to IL-33 and its downstream mediator IL-6, CD276 may have a role in the activation of STAT3 downstream signaling, which enhances stem-like characteristics in glioma cells and induces an anti-inflammatory phenotype in TAMs [67,68].